Kaloba

Pelargonium sidoides root liquid extraction preparation, the active ingredient in Kaloba, is a herbal botanical presented as a liquid oral preparation for oral use. It is traditionally used to support respiratory health in adults and children with mild to moderate upper respiratory symptoms.

GNH USA supplies Kaloba as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Kaloba, containing Pelargonium sidoides extract, is used primarily for conditions affecting the upper respiratory tract.

- Acute bronchitis: may help reduce cough frequency and improve sputum clearance. - Common cold: can alleviate nasal congestion, sore throat and mild fever. - Sinusitis: supports sinus drainage and reduces facial pressure. - Post‑viral cough: may shorten the duration of lingering cough after viral infections.

Kaloba is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Mild gastrointestinal upset (nausea, dyspepsia) - Altered taste sensation - Headache - Dizziness - Transient skin flushing - Mild allergic skin rash

Serious or Rare Side Effects: - Anaphylactic reaction - Severe urticaria or angioedema - Hepatic enzyme elevation - Acute bronchospasm in hypersensitive individuals - Persistent diarrhea leading to dehydration

When considering Kaloba, several safety measures are recommended.

- Hypersensitivity: avoid if known allergy to Pelargonium species. - Liver disease: use with caution and monitor hepatic function. - Pregnancy and lactation: safety not established; consult a healthcare professional. - Pediatric use: limit to age groups advised by a clinician. - Concomitant immunomodulators: monitor for exaggerated immune response. - Store at ambient temperature: keep below 25°C, protect from moisture and direct sunlight.

Potential drug interactions with Kaloba should be reviewed before use.

Major Interactions (Avoid): - Concurrent use with other potent immunostimulants may increase risk of autoimmune reactions. - Known severe allergy to related herbal extracts.

Moderate Interactions (Monitor Closely): - Anticoagulants (e.g., warfarin): possible increased bleeding tendency. - CYP450 substrates: uncertain effect on metabolism, monitor therapeutic levels. - Antihypertensive agents: may enhance blood pressure‑lowering effect. - Antidiabetic drugs: potential for altered glucose control. - Other respiratory herbal preparations: risk of additive cough‑suppressant effect.